Company: OMTK
Filing Date: 2025-08-19
Form Type: 10-Q
Source: 0001096906-25-001378
Chunk: 16

Company: Omnitek Engineering Corp
Filing Date: 2025-08-19
Form: 10-Q
Item: Item 2
Chunk 16
---
 working capital of $1,209,105.

We have no firm commitments or obligations for capital expenditures. However, substantial discretionary expenditures may be required to enable us to conduct existing and planned product research, design, development, manufacturing, marketing, and distribution of our products. We may need to raise additional capital to facilitate growth and support our long-term product development, manufacturing, and marketing programs. The Company has no established bank-financing arrangements. Therefore, it is possible that we may need to seek additional financing through subsequent future public or private sales of our securities, including equity securities. We may also seek funding for the development, manufacturing, and marketing of our products through strategic partnerships and other arrangements with corporate partners. There can be no assurance, however, that such collaborative arrangements or additional funds will be available when needed, or on terms acceptable to us, if at all. If adequate funds are not available, we may be required to curtail one or more of our research and development programs.

We have historically incurred significant losses, which have resulted in a total accumulated deficit of $21,928,291 at June 30, 2025. 

Page 18

Operating Activities

We realized a negative cash flow from operations of $128,809 for the six months period ended June 30, 2025 compared with a negative cash flow of $29,514 during the six months period ended June 30, 2024. Included in the operating income of $99,193 for the six months period ended June 30, 2025 are non-cash expenses, which are not a drain on our capital resources. During the period, these non-cash expenses include the value of options granted in the amount of $3,782 and depreciation and amortization of $1,928. Additionally, the operating income included general and administrative expenses of $282,346 and research and development expenses of $35,305. 

Financing Activities

We realized $57,000 positive cash flow from financing activities for the six months period ended June 30, 2025, compared with $0.00 cash flow for the six month period ended June 30, 2024. 

Investing Activities

There was $0.00 cash flow from investing activities for the six month period ended June 20, 2024 compared with a negative $6,336 cash flow from investing activities for the six month period ended June 30, 2024. 

Off-Balance Sheet Arrangements

None.

Critical Accounting Policies